Noah Clauser

Chief Financial Officer at Astria Therapeutics

Mr. Clauser has been with Catabasis for nine years, including the last three years as Vice President, Finance. He has nearly 20 years of financial experience, and served as an Accounting Manager at Impress Software before joining Catabasis.

“I am excited for this new opportunity as we approach the next stage of our company, with top-line results from the Phase 3 PolarisDMD trial for edasalonexent expected in the fourth quarter of this year,” said Mr. Clauser. “I am looking forward to continuing our work to make an impact in the lives of patients and families affected by Duchenne muscular dystrophy.”

Links

Timeline

  • Chief Financial Officer

    September 23, 2020 - present

View in org chart